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The role of PR-Set7 in replication licensing
depends on Suv4-20h
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PR-Set7 is the sole monomethyltransferase responsible for H4K20 monomethylation (H4K20me1) that is the
substrate for further methylation by Suv4-20h1/h2. PR-Set7 is required for proper cell cycle progression and is
subject to degradation by the CRL4Cdt2 ubiquitin ligase complex as a function of the cell cycle and DNA damage.
This report demonstrates that PR-Set7 is an important downstream effector of CRL4Cdt2 function during origin of
DNA replication licensing, dependent on Suv4-20h1/2 activity. Aberrant rereplication correlates with decreased
levels of H4K20me1 and increased levels of H4K20 trimethylation (H4K20me3). Expression of a degradation-
resistant PR-Set7 mutant in the mouse embryo that is normally devoid of Suv4-20 does not compromise
development or cell cycle progression unless Suv4-20h is coexpressed. PR-Set7 targeting to an artificial locus
results in recruitment of the origin recognition complex (ORC) in a manner dependent on Suv4-20h and
H4K20me3. Consistent with this, H4K20 methylation status plays a direct role in recruiting ORC through the
binding properties of ORC1 and ORCA/LRWD1. Thus, coordinating the status of H4K20 methylation is pivotal for
the proper selection of DNA replication origins in higher eukaryotes.
[Keywords: H4K20; ORC; PR-Set7; Suv4-20; cell cycle; chromatin]
Supplemental material is available for this article.
Received May 3, 2012; revised version accepted October 15, 2012.
The proper maintenance and control of genome integ-
rity is an important and well-coordinated process. Many
factors function to coordinate the proper progression of
the cell cycle, including those that directly regulate the
chromatin states critical for replication, mitotic conden-
sation, and cell division. Central among these chromatin-
associated cell cycle regulators is PR-Set7/Set8/Setd8, the
sole mammalian histone H4K20monomethyltransferase.
In embryonic stem (ES) and differentiated cells, PR-Set7
deletion results in massive DNA damage and defects in
cell cycle progression (Beck et al. 2012), leading to an
accumulation of cells in G2/M phase (Jorgensen et al.
2007; Tardat et al. 2007; Houston et al. 2008; Oda et al.
2009). Moreover, PR-Set7 is degraded prior to S phase and
after UV damage by a PCNA/CRL4Cdt2-dependent mech-
anism, a conserved means to regulate origins of DNA
replication licensing (Abbas et al. 2010; Centore et al. 2010;
Oda et al. 2010; Tardat et al. 2010). Thus, the oscillation of
PR-Set7 levels during the cell cycle suggests a means by
which H4K20 methylation (H4K20me) regulates cell cycle
progression. To date, there are only two known substrates
for PR-Set7—H4K20 and p53K382—with most functions
attributed to PR-Set7 resting on its catalysis of H4K20
monomethylation (H4K20me1) (Beck et al. 2012).
H4K20me is unique among histonemodifications in that
it oscillates during the cell cycle. The levels of H4K20me
are directly controlled by three sets of enzymes. PR-Set7
catalyzes H4K20me1, which is required for subsequent
catalysis of H4K20 di/trimethylation (H4K20me2/3)
(Nishioka et al. 2002; Rice et al. 2002) via the activity
of Suv4-20h1/h2 (Schotta et al. 2008), or is subject to
demethylation, along with H3K9me1, by PHF8 activity
(Liu et al. 2010; Qi et al. 2010 ). Misregulation of PR-Set7
or Suv4-20h1/h2 (Suv4-20h) causes increased sensitivity
to DNA damage and defects in the cell cycle (Schotta
et al. 2008; Oda et al. 2009).
How PR-Set7 and H4K20me1 function to regulate the
cell cycle remains an open question. PR-Set7 is normally
absent during DNA replication and peaks during mitosis.
In addition, the deletion or knockdown of PR-Set7 gives rise
to marked defects in both mitosis and S phase. More
recently, gain-of-function experiments have suggested a role
for PR-Set7 in proper DNA replication (Abbas et al. 2010;
Tardat et al. 2010). Expression of a nondegradable PR-Set7
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mutant, PR-Set7PIPM2 (PCNA-interacting peptide [PIP]
degron mutant), is highly toxic, and this toxicity is de-
pendent on PR-Set7 catalytic activity (Abbas et al. 2010;
Centore et al. 2010). While this phenomenon may be due
to a multitude of reported defects, a leading culprit is the
uncontrolled rereplication of the genome upon expression
of PR-Set7PIPM2. Consistent with this, loss of PR-Set7
enzymatic activity causes defects in origin of replication
firing (Jorgensen et al. 2007; Tardat et al. 2007).
The mechanisms behind origin of replication firing in
higher eukaryotes are poorly understood. In contrast to
the case of lower eukaryotes, there is no evidence of a
sequence-specific directed mechanism for origin recogni-
tion and firing (Gilbert 2010). For this reason, other
features of chromatin are candidates as the targets for
recruitment of the DNA replicationmachinery, although,
as yet, no specific histone post-translational modification
has correlated with origins of replication (Karnani et al.
2010; Eaton et al. 2011; Mesner et al. 2011). Because
origin of replication firing does correlate with PR-Set7
activity, PR-Set7 and/or H4K20me1 may potentially pro-
vide a chromatin-dependent mechanism for recruitment
of the origin recognition complex (ORC).
In this study, we sought to determine how PR-Set7
functions in the origin of replication licensing pathway.
We found that the rereplication phenotype caused by loss
of the CRL4Cdt2 ubiquitin ligase complex is fully rescued
upon codepletion of PR-Set7. Either Cdt2 knockdown or
PR-Set7 stabilization results in increased global levels of
H4K20me3, suggesting that H4K20me3 is a key effector
in the rereplication pathway. In line with this, we show
that the defects in cell cycle progression and massive
DNA damage that result when cells are exposed to a
degradation-resistant version of PR-Set7 are a conse-
quence of Suv4-20h activity. Forced targeting of PR-Set7
using a GAL4-UAS system results in elevated H4K20me3
at this locus and increased ORC recruitment, while
depletion of Suv4-20h1 led to a drastic reduction in
ORC recruitment. This recruitment involves two differ-
ent components of ORC—ORC1 and ORCA (LRWD1)—
that bind directly to H4K20me2/3 in vitro. Our results
suggest that PR-Set7 modulates the chromatin environ-
ment such that the chromatin is permissive for replica-
tion firing through the downstream action of Suv4-20.
Results
PR-Set7 is a major downstream effector of Cdt2
function
During our initial characterization of PR-Set7PIPM2, we
noticed that expression of thismutant elicited toxic effects
in a variety of cell lines (Supplemental Fig. 1A). PR-
Set7PIPM2 contains mutations in the second PIP domain,
PIP degron, that inhibit PR-Set7 binding to PCNAand thus
blocks the normal process of PCNA-dependent CRL4Cdt2-
mediated degradation of PR-Set7 after UV damage and
during S phase (Abbas et al. 2010; Centore et al. 2010; Oda
et al. 2010; Tardat et al. 2010). PR-Set7 also contains
another PIP domain (PIP1) that is not required for PCNA
binding or CRL4Cdt2-mediated degradation (Supplemental
Fig. 1A). We first readdressed whether expression of PR-
Set7PIPM2 has an effect on cell cycle progression. We
expressed a retrovirus encoding PR-Set7PIPM2 in HeLa and
U2OS cells that led to sustained PR-Set7 levels, as expected
(Supplemental Fig. 1B; data not shown). HeLa cells express-
ing PR-Set7PIPM2 displayed an altered cell cycle profile with
increased population of cells within G2/M phase along
with an increased number of cells containing +4n DNA
content and increased nuclear volume that are replicating
DNA (EdU+) (Fig. 1A; Supplemental Fig. 1C), suggesting
rereplication or aberrant origin of replication firing in
agreement with previous observations (Abbas et al. 2010;
Tardat et al. 2010). Thus, stabilization of PR-Set7 during S
phase leads to increased rereplication and G2/M arrest,
a unique characteristic of proteins that regulate origin of
replication licensing (Arias and Walter 2007; Abbas and
Dutta 2011; Havens and Walter 2011), and suggests that
the abnormal persistence of PR-Set7 throughout the cell
cycle leads to cell cycle alterations.
To address this hypothesis directly, we next sought to
determine whether the cell cycle defects seen in cells
lacking Cdt2 were due to excess PR-Set7 using RNAi-
mediated knockdown of Cdt2, PR-Set7 itself, and another
Cdt2 degradation target, Cdt1. Cdt2 has been previously
shown to participate in cell cycle-regulated degradation of
PR-Set7, andwe found that uponCdt2 knockdown, PR-Set7
was stabilized (Fig. 1B; Oda et al. 2010 ). Importantly, loss of
Cdt2 also gave rise to robust defects in cell cycle pro-
gression, including G2/M arrest and rereplication (Fig. 1C;
Supplemental Figs. 2, 3A). Because this phenotype might
potentially be due to other Cdt2 targets, we tested whether
the stabilization of Cdt1 might contribute to this effect by
performing double-knockdown experiments. Depletion of
PR-Set7 or Cdt1 rescued the cell cycle arrest observed in
cells lacking Cdt2, suggesting that Cdt2 regulates cell cycle
progression through control of both PR-Set7 andCdt1 levels
(Fig. 1C; Supplemental Figs. 2, 3A). On the other hand,
PR-Set7 siRNA treatment was unable to rescue the cell
cycle arrest observed upon knockdown of another, more
promiscuous member of the CRL4Cdt2 complex, DDB1
(Supplemental Fig. 4A,B). These findings indicate that
PR-Set7 is a specific, critical downstream effector of
CRL4Cdt2-regulated origin of replication licensing.
CRL4 Cdt2 has a well-characterized role in regulating
the dynamics of origins of DNA replication. To determine
the mechanism by which PR-Set7 and Cdt2 may regulate
origin of replication licensing, we examined the effects of
loss of Cdt2 and PR-Set7 on H4K20 methylation. Loss of
Cdt2 alone resulted in PR-Set7 stabilization along with
a decrease in H4K20me1 levels and a concomitant in-
crease in H4K20me3 (Fig. 1B). The elevated levels of PR-
Set7 likely led to increased levels of H4K20me1 that was
efficiently converted to H4K20me3 (Abbas et al. 2010). In
keeping with this, the increase in H4K20me3 levels was
reversed upon codepletion of PR-Set7, suggesting that a
potential cause of rereplication is the overabundance of
H4K20me3. In contrast, codepletion of Cdt1 did not restore
H4K20me3 levels (Fig. 1B). Although the observed alter-
ations inH4K20me3 levels likely reflect changes in PR-Set7
PR-Set7 and Suv4-20h in DNA replication
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levels, we cannot exclude the possibility that changes in
the cell cycle may contribute. Our findings are partially
consistent with a recent report indicating that H4K20me3
levels are elevated during G1/S phase (Zee et al. 2012).
Suv4-20h1/h2 are required for PR-Set7PIPM2-mediated
cell cycle defects in differentiated cells
Despite the defined role of H4K20me1 in mitotic con-
densation, it is not clear how this modification is bi-
ologically relevant during DNA replication, since both
PR-Set7 and H4K20me1 are mostly absent during S phase.
As a first step toward understanding this enigma, we
sought to determine whether the function of PR-Set7
during DNA replication was dependent on the down-
stream di- and trimethylation states of H4K20me cata-
lyzed by Suv4-20h1/h2 (Schotta et al. 2008), given that
H4K20me2/3 are at their highest levels during G1 and S
phases (Abbas et al. 2010). To test this possibility, we
generated wild-type and Suv4-20h1/h2/ mouse embry-
onic fibroblasts (MEFs) (Suv4-20 dn) in which the PR-
Set7PIPM2 is expressed under the control of an inducible
Figure 2. PR-Set7PIPM2 toxicity is dependent on Suv4-20 and H4K20me2/3 in MEFs. (A) Proliferation of wild-type (wt) and Suv4-20/
MEFs after inducible expression of Flag-HA PR-Set7PIPM2. Induction of PR-Set7PIPM2 after addition of doxycycline and dexamethasone
at day 0. (B) Western blot of wild-type and Suv4-20/MEF lysates after inducible expression of PR-Set7PIPM2. (C) FACS analysis of cell
cycle distribution of wild-type and Suv4-20/ MEFs before and after induction of PR-Set7PIPM2. (D) FACS analysis of cell cycle
distribution of wild-type and Suv4-20/ MEFs before and after treatment with siRNA against Cdt2. (E) DAPI staining and
quantification of the nuclear size of wild-type and Suv4-20/ MEFs after induction of PR-Set7PIPM2. n = 3 for proliferation and cell
cycle experiments. (*) Statistical significance with P < .05.
PR-Set7 and Suv4-20h in DNA replication
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doxycycline/dexamethasone-responsive promoter (Fig. 2B).
Expression of PR-Set7PIPM2 in wild-type MEFs caused a
striking reduction in growth rate (Fig. 2A) but was ineffec-
tual in the case of Suv4-20 dnMEFs (Fig. 2A). Expression of
the PR-Set7PIPM2 led to both a slight decrease inH4K20me1
levels and an increase in H4K20me3 levels in wild-type
MEFs, neither of whichwas observed in the case of Suv4-20
dn MEFs (Fig. 2B). These results implicate a globally in-
creased transition from the mono- to the trimethylated
state of H4K20 in the pathway leading to cell cycle defects
mediated by PR-Set7PIPM2.
We next compared the cell cycle profile of wild-type and
Suv4-20 dnMEFs as a function of PR-Set7PIPM2 expression.
In contrast to wild-type MEFs in which PR-Set7PIPM2
expression led to a 2.5-fold increase in G2/M-phase cells,
similar to our observation in HeLa cells and earlier work
by other groups (Centore et al. 2010; Tardat et al. 2010),
Suv4-20 dnMEFs did not display changes in the cell cycle
profile upon expression of PR-Set7PIPM2 (Fig. 2C). Simi-
larly, Cdt2 siRNA treatment of wild-type but not Suv4-20
dn MEFs caused an accumulation of cells in G2/M phase
(Fig. 2D; Supplemental Fig. 3B). Importantly, untreated
wild-type and Suv4-20 dn MEFs have similar amounts of
cells in G2/M phase (Supplemental Fig. 5). Finally, while
wild-type MEFs showed increased nuclear volume upon
induction of PR-Set7PIPM2 expression, this was not the case
for Suv4-20 dn MEFs (Fig. 2E). These combined results
demonstrate that the cell cycle progression defects caused
by PR-Set7 stabilization during S phase are dependent on
Suv4-20h and its products, H4K20me2/3.
Absence of H4K20me3 prevents toxicity of PR-Set7PIPmt
and DNA damage in PR-Set7/ early embryos
We previously showed that deletion of PR-Set7 in mice
results in embryonic death at the transition between the
four- and eight-cell stage (Oda et al. 2009). This lethality
can be rescued upon reintroduction of a catalytically
active PR-Set7 into PR-Set7/ embryos. In contrast to
other cell types in which PR-Set7 is depleted, there is no
accumulation of DNA damage in the PR-Set7/ embryo
(Oda et al. 2009). To better understand the aberrant
functioning of PR-Set7PIP mutants in vivo, we first in-
vestigated whether PR-Set7PIPM1M2 expression could res-
cue the PR-Set7/ embryos. We collected two-cell stage
embryos from PR-Set7/+ crosses and injected one of the
two cells with mRNA encoding PR-Set7PIPM1M2 along
with mRNA encoding a fluorescent marker as a lineage
tracer (Fig. 3A). In this way, if PR-Set7PIPM1M2 is able to
rescue the lethality caused upon loss of PR-Set7, the
injected cell of the two-cell stage embryo of PR-Set7/
embryos is expected to develop as normal and generate
a blastocyst, while the other cell would serve as an
internal control (Fig. 3A; Oda et al. 2009). Also, these
experiments should reveal whether wild-type and hetero-
zygous embryos would tolerate PR-Set7PIPM1M2 expression
(Fig. 3A). Surprisingly, expression of PR-Set7PIPM1M2 was
able to completely rescue the PR-Set7/ embryos (Fig. 3B).
Moreover, PR-Set7PIPM1M2 was tolerated in wild-type and
heterozygous embryos (Fig. 3B). Importantly, expression
of PR-Set7PIPM1M2 in embryonic nuclei did not lead to
increased accumulation of gH2A.X (Fig. 3D). These re-
sults are in stark contrast to the phenotype observed
upon expression of PR-Set7PIPM1M2 in differentiated
cells, which led to the accumulation of DNA damage
as well as multiple cell cycle defects, including G2/M-
phase arrest and rereplication (Abbas et al. 2010; Tardat
et al. 2010). Thus, the early embryo appears to contain
control mechanisms for cell cycle progression and
checkpoint control that are distinct from those within
differentiated cell lines.
A particular feature of early embryonic chromatin is
the absence of most typical heterochromatic marks, in-
cluding H4K20me3 (Kourmouli et al. 2004; Burton and
Torres-Padilla 2010). Given our results above, the lack of
Suv4-20h activity in the early embryo may explain why
PR-Set7PIPM1M2 does not result in growth arrest and ele-
vated DNA damage. Thus, we next investigated whether
coexpression of Suv4-20h1 in the embryo would lead to the
toxicity associated with PR-Set7PIPM1M2 in differentiated
cells. Indeed, in contrast to injection of the PR-Set7PIPM1M2
transcript alone, coinjection with the Suv4-20h1 tran-
script failed to rescue the PR-Set7-null embryos. In-
stead, expression of PR-Set7PIPM1M2 and Suv4-20h1 caused
growth arrest and high levels of gH2A.X (Fig. 3C). This
toxicity occurred independently of the PR-Set7 embryo
genotype. These findings show that the toxic effects
caused by stabilization of PR-Set7 during S phase are
mediated through Suv4-20 and, likely, H4K20me2/3.
Contrary to ES cells and transformed cells, loss of PR-
Set7 in the early embryo does not trigger DNA damage
(Jorgensen et al. 2007; Oda et al. 2009). The results above
suggest that the difference between PR-Set7 phenotypes
in the early embryo, compared with ES cells and trans-
formed cell lines, is dependent on Suv4-20. In support of
this hypothesis, PR-Set7/ embryos show massive DNA
damage only when injected with Suv4-20h1 mRNA, as
demonstrated by gH2A.X accumulation (Fig. 3E). Impor-
tantly, expression of Suv4-20h1 in wild-type or heterozy-
gous embryos did not elicit DNA damage (Fig. 3E).
Altogether, the lack of Suv4-20h activity in the normal
embryo revealed two insights into PR-Set7 biology during
S phase: The PR-Set7PIPM2-mediated toxicity and the
DNA damage incurred upon loss of PR-Set7 are both
dependent on Suv4-20h and H4K20me2/3. These results
confirm that PR-Set7 has essential functions in the
embryo unrelated to Suv4-20h, but that those related to
S phase in differentiated cells can be recapitulated in
embryos forced to express Suv4-20h.
PR-Set7 recruits the ORC through direct binding
of ORC1 and ORCA to H4K20me2/3
Given our findings that PR-Set7 misregulation leads to
disruption in the cell cycle and abnormal DNA replication
through Suv4-20h and H4K20me2/3, we next explored the
mechanistic basis for the link between H4K20me2/3 and
appropriate DNA replication. Our previous work, along
with that of others, has shown that the ORC binds to
H4K20me2/3 in vitro (Oda et al. 2010; Vermeulen et al.
Beck et al.
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2010). We hypothesized that H4K20me2/3 may serve as
a recruitment mechanism for specific components of the
ORC. To test this hypothesis, we first examined whether
artificial recruitment of GAL4-PR-Set7 to a UAS site
would lead to ORC recruitment. Using a 293T-REx cell
line containing a stably integrated 5xUAS site directing
luciferase expression, we expressed GAL-4 PR-Set7 under
an inducible doxycycline-responsive promoter (Fig. 4A; Li
et al. 2010). Chromatin immunoprecipitation (ChIP) anal-
ysis was performed at the UAS site as a function of GAL4-
PR-Set7 expression. PR-Set7 recruitment to the artificial
UAS locus led to an approximately fourfold increase in
ORCA and an approximately fivefold increase in ORC1
recruitment relative to untreated cells (Fig. 4B). Coinci-
dent with this recruitment was a statistically significant
accumulation of H4K20me3 at the UAS site, which was
generated from an earlier accumulation of H4K20me1 (Fig.
4B). Upon siRNA treatment for Suv4-20h1, H4K20me3
decreased at the UAS site with a concomitant reduction
in ORC-1 and ORCA recruitment (Fig. 4B; Supplemental
Fig. 3). These data confirm that PR-Set7 participates in
ORC recruitment at specific loci, without the requirement
for any upstream factors, through Suv4-20 and H4K20me3
(Tardat et al. 2010).
After determining that ORC can be directly recruited
to chromatin by PR-Set7, we next tested whether any
ORC components can directly bind H4K20me2/3. After
analyzing predicted chromatin-binding domains (http://
www.uniprot.org), we found that only two members of
ORC could potentially accomplish this function: ORC1
with its BAH domain and ORCA with its WD40 domain.
Recently, the ORC1 BAH domain was shown to specifi-
cally bind H4K20me2, further supporting this connection
(Kuo et al. 2012). We used the BAH domain of ORC1
(amino acids 1–185) and full length ORCA in peptide-
binding studies. The ORC-1 BAH domain bound primarily
H4K20me2 in vitro (Fig. 4C). In contrast, ORCA showed
a preference for H4K20me3. Thus, in combination with
our previous unbiased peptide-binding experiments (Oda
et al. 2010), these findings demonstrate that both ORC1
Figure 3. Both PR-Set7PIPM2 and PR-Set7/ phenotypes are dependent on Suv4-20 in the early embryo. (A) Two-cell stage embryo
injection experiment schematic depicting the possible outcomes for wild-type and heterozygous PR-Set7 embryos versus the null
embryos. (B) PR-Set7+/ and PR-Set7/ two-cell stage embryos were injected with PR-Set7PIPM1M2 mRNA. Injected cells are marked
with GFP; the polar body is labeled by arrowheads, and GFP+ cells are indicated by arrows. Embryos were monitored for growth and
stained with H4K20me1 (red). Full Z-series projections and single sections are depicted. (C) PR-Set7/+ and PR-Set7/ were injected
with mRNA for PR-Set7PIPM1M2 in combination with Suv4-20h1 mRNA and GFP as a tracer. The arrows point to one of the injected
cells. Embryos were stained with H4K20me3 (red) and gH2A.X (yellow). Insets show an injected cell stained for H4K20me3 (red) and
DAPI (blue). (D) PR-Set7/+ and PR-Set7/ were injected with PR-Set7PIPM1M2. Arrows point to injected cells, which were identified by
the presence of GFP; the polar body is marked by arrowheads. Embryos were stained with gH2A.X, cortical actin, and DAPI (blue). (E)
PR-Set7/ and PR-Set7/+ embryos were injected with Suv4-20h1 mRNA alone and stained for cortical actin (green) and gH2A.X (red)
accumulation. Injected cells (marked by arrows) were identified by the presence of GFP (not shown). The genotypes of individual
embryos were determined after confocal acquisition as described previously.
PR-Set7 and Suv4-20h in DNA replication
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and ORCA are involved in recruitment of the ORC to
H4K20me2/3 sites. Together, our results show a direct
mechanistic connection between PR-Set7 and the proper
recruitment of the ORC through the products of Suv4-20
activity to effectively promote DNA replication.
Discussion
In this study, we showed that the oscillation in PR-Set7
protein levels during the cell cycle has direct repercus-
sions on the proper recruitment of the ORC through
H4K20me2/3 and Suv4-20h (Fig. 5). The disruption in PR-
Set7 oscillation and the associated catalysis of H4K20me1
lead to faulty DNA replication. Since the initial identifi-
cation of PR-Set7 and Suv4-20, H4K20me has been func-
tionally linked to proper cell cycle progression, specifically
during mitosis and DNA replication (Fig. 5). This study
places PR-Set7 and Suv4-20h as key chromatin mediators
of DNA replication and specifies how their activities
function in conjunction to ensure bona fide ORC recruit-
ment to chromatin in higher eukaryotic cells.
We found that aberrant PR-Set7 stabilization during S
phase causes robust rereplication. Rereplication was pre-
viously shown to be caused by the loss of the ubiquitin
ligase Cdt2 (Arias and Walter 2007), and this abnormality
can be completely suppressed by codepletion of PR-Set7.
These results place PR-Set7 as a major effector of Cdt2
function. We also found that cell cycle defects in MEFs
that express PR-Set7PIPM2 are dependent on Suv4-20h and
H4K20me2/3. Surprisingly, expression of PR-Set7PIPM1M2
is not toxic during early embryogenesis and can even
rescue PR-Set7/ embryos to an extent similar to wild-
type PR-Set7. This is due to the minimal amount of
H4K20me2/3 inherent to early embryogenesis. Consistent
with this interpretation, coexpression of PR-Set7PIPM1M2
along with Suv4-20h1, as opposed to expression of either
gene alone, caused growth arrest in the embryo. Together,
these results connect PR-Set7 and Suv4-20h with regula-
tion of replication during S phase and DNA damage and
accentuate that different regulatory processes guide the
cell cycle between the early embryo and differentiated
cells. Finally, we determined how H4K20me affects origin
licensing by demonstrating that PR-Set7 can trigger re-
cruitment of the ORC to chromatin and that ORC1 and
ORCA bind H4K20me directly.
The sequence and determinants of origins of DNA
replication in higher eukaryotes have remained elusive
despite extensive investigation (Gilbert 2010). The meta-
zoan ORC does not contain any intrinsic DNA-binding
specificity and thus must require additional factors to be
properly recruited. A leading hypothesis in the field has
been that chromatin may be involved in this process. Our
study provides mechanistic insights into how H4K20me
may function during this critical process. Taken together,
the regulation and timing of H4K20me1/2/3 is critical for
proper origin of replication firing.
Figure 4. PR-Set7 recruits the ORC to chromatin through H4K20me. (A) Diagram depicting the GAL4-UAS system in 293T-REx cells.
(B) ChIP analysis at an integrated UAS-binding site in 293T-REx cells before and after inducible expression of GAL4-PR-Set7 using
GAL4, PR-Set7, H3, H4K20me1, H4K20me3, ORC1, and ORCA antibodies. (C) Peptide pull-down for the GST-ORC1 BAH domain and
His-ORCA binding to unmethylated, H4K20me1, H4K20me2, and H4K20me3 peptides. (*) Statistical significance with P < 0.05.
Figure 5. Summary of function of PR-Set7
and Suv4-20 (A) along with their role in
regulation of origin of replication licensing
through CRL4Cdt2 (B).
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In vivo, H4K20 is primarily found in both the mono-
and dimethylation state, raising the question of how
these highly ubiquitousmodifications affect the selection
of DNA replication origins. Our findings, along with the
previously demonstrated importance of regulation and
timing of H4K20 methylation, suggest that H4K20me3,
rather than H4K20me2, acts as a more specific guide for
origin of replication selection, although both marks may
contribute to this process. This situates H4K20me and
the degree of such methylation as key components in an
oscillating control mechanism for proper cell cycle pro-
gression, controlled in part by the degradation of PR-Set7.
In addition, differential regulation of these modifications
between the early embryo and later lineage-committed
cells demonstrates the contrasting requirements for cell
cycle progression during development.
Materials and methods
Microinjection and embryo analysis
Two-cell stage mouse embryos were isolated from PR-Set7/+
crosses at 46 h post-hCG hormonal stimulation. Embryos were
microinjected with 1–2 pL of mRNA transcribed in vitro from
the pRN3P expression vector that contains 59 and 39 untrans-
lated regions (UTRs) of the b-globin as described previously (Oda
et al. 2009). Embryos were cultured in KSOM droplets under
mineral oil under a 5% CO2 atmosphere at 37°C and monitored
for developmental progression daily. For immunostaining, em-
bryos were fixed as described earlier (permeabilization with
0.5% Triton and washed three times in PBS-T [0.1% Tween in
PBS]), blocked, and incubated with the primary antibodies in 3%
BSA and 0.1% Tween in PBS for ;12 h at 4°C. Embryos were
then washed twice in PBS-T, blocked for 30 min, and incubated
with the corresponding secondary antibodies and 49-6-diamidino-
2-phenylindole. Embryos were then analyzed in individual drops
using a TCS SP5 confocal microscope (Leica) and genotyped after
acquisition.
Cell culture and flow cytometry
Suv4-20/ and wild-type MEFs were kindly provided by Drs.
Gunnar Schotta and Thomas Jenuwein. 293T-REx cells were
purchased from Invitrogen, and HeLa and U2OS were acquired
from the American Type Culture Collection (ATCC). Cells were
grown using DMEM, 10% FBS, 1% penicillin, 1% streptomycin,
and 1% nonessential amino acids. For proliferation assays, cells
were counted using a hemacytometer or cyto60 dye (Invitrogen).
For flow cytometry, cells were trypsinized, washed once in cold
PBS, and fixed in 70% ethanol for 20 min on ice. For cell cycle
analyses, cells were washed and resuspended in PBS containing
RNase A (100 mg/mL) and propidium iodide (40 mg/mL). EdU
labeling was performed using the Click-iT EDU Alexa Fluor 488
flow cytometry assay kit (Invitrogen). Samples were run on a
FACScalibur (Becton Dickinson), and data analysis was per-
formed using FloJo (Dean-Jett-Fox cell cycle analysis platform)
and ModFit LT 3.2.1.
Protein extracts and microscopy
Cells were lysed with buffer A (10 mM HEPES at pH 7.9, 0.1%
NP-40, 10 mM MgCl2, 250 mM sucrose) containing protease
inhibitors (Roche) and centrifuged. Nuclear pellets were lysed
with buffer B (25 mM HEPES at pH 7.9, 20% glycerol, 0.7 M
NaCl, 1.5 mM MgCl2, 0.1 mM EDTA), sonicated, and centri-
fuged. Proteins were separated on sodium dodecyl sulfate–
polyacrylamide gels. For microscopy, cells were grown on
coverslips, fixed with 4% paraformaldehyde, and stained using
DAPI dye.
Gene silencing by siRNA and quantitative PCR (qPCR)-based
detection
siRNA transfections were performed using RNAiMAX (Invitro-
gen) according to the manufacturer’s specifications. The nucle-
otide sequences of siRNA and the primers used for detection are
listed below. siRNAs for Hs PR-Set7 and si-AllStars as a negative
control were purchased fromQiagen. siRNAs for Hs Cdt2 and Hs
DDB1 were obtained from Invitrogen. siRNAs for Hs Cdt1, Hs
Suv4-20h1, and Mm Cdt2 were ordered from Dharmacon.
siRNA oligos used were as follows: Hs PR-Set7-7 (target
sequence: CTGCAGTCTGAAgAAAGGAAA), Hs PR-Set7-8
(sense, CCUGUUGAUUGCCAAAAACTTdTdT; antisense, GUU
UUUGGCAAUCAACAGGdTdT), Hs Cdt2-1 (sense, GAAUUAU
ACUGCUUAUCGAdTdT; antisense, UCGAUAAGCAGUAUAA
UUCdTdT), Hs DDB1-1 (sense, ACAGAGUGGCGAGAGCAUU
dTdT; antisense, AAUGCUCUCGCCACUCUGUdTdT), Hs DD
B1-2 (sense, CCUGUUGAUUGCCAAAAACTTdTdT; antisense,
GUUUUUGGCAAUCAACAGGdTdT), Hs Cdt-1 (Dharmacon si
genome pool), and Mm Cdt-2 (Dharmacon si genome pool).
Detection primers used were as follows: Hs Cdt1 1508 S
(GCTGTTGTACTATCATGAGCCC), Hs Cdt1 1626 AS (GTCC
AGCTTGACGTAGGTGTC), Hs Cdt2 308 S (GACCCTGATGC
TCTTCAATTC), Hs Cdt2 402 AS (ACCACTGCACTGATAAC
CAGTC), Mm Cdt2 24 S (ACGATGAACACACGTCTTATGG),
Mm Cdt2 357 AS (AGCCTTCTTCATTAGCAACTGC), Mm
mGapdh S (CAAGCTCATTTCCTGGTATGAC), Mm Gapdh
AS (CTCCTGTTATTATGGGGGTCTG), Hs Gapdh S (AACCA
TGAGAAGTATGACAACAGC), and Hs Gapdh AS (CAGTCT
TCTGGGTGGCAGTG).
Plasmids
Human PR-Set7 wild-type and mutants were subcloned into the
pMSCV Puro retroviral vector (Invitrogen). pINTO GAL4 PR-Set7
and 3xFlag-tagged PR-Set7were cloned as an XhoI/BamHI fragment
into the pMSCV TtIGPP vector (S. Lowe Laboratory, Cold Spring
Harbor Laboratory [CSHL]). iTetONGR* (Anastassiadis et al. 2002)
was cloned as an EcoRI/BamHI fragment into pMSCV MB
(M. Huebner, CSHL). Additional Suv4-20h1 and PR-Set7PIPM1M2
were cloned into the pRNP3 vector. ORC-1 and ORCA domains
were cloned from HeLa cDNA into pGEX6P1 (GE Life Sciences)
and pET30a (Novagen), respectively, using BamHI and NotI
restriction enzymes. Retrovirus was produced in 293T cells
according to standard methods and then used to infect MEFs.
Antibodies and reagents
The sources for the following reagents were as follows: PR-Set7
(custom), H3 (Abcam), H4K20me1 (Abcam), H4K20me3 (Abcam),
gH2A.X (Millipore), DDB1 antibody (Invitrogen), b-tubulin
(Abcam), PCNA (Santa Cruz Biotechnology), actin (Abcam),
ORC1 (Abcam), ORCA (Bethyl), and GAL4 (Millipore).
ChIP
ChIP was performed using 293T-REx inducible cell lines with a
stably inserted 6xUAS-TK-LUC. ChIP was performed 48 h after
induction of GAL4-PR-Set7 expression using 1 mg/mL doxycy-
cline. Detectionwas performed using primers against the TK Luc
promoter (59-CACCGAGCGACCCTGCATAAG-39 and 59-GCT
PR-Set7 and Suv4-20h in DNA replication
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TCTGCCAACCGAACGGAC-39). ChIP protocol was performed
as described previously (Gao et al. 2012).
Peptides and recombinant pull-downs
GST-ORC1 BAH domain (amino acids 1–185) and His-ORCA
(full length) were incubated with biotinylated H4 peptides
(amino acids 9–28) with specified post-translational modifica-
tions. One microgram of the above recombinant protein was
incubated with 1 mg of peptide (preincubated with Streptactin
macroprep beads [IBA]) for 4 h to overnight and thenwashed with
10mM Tris (pH 7.9), 500 mM KCl, 0.2mM EDTA, and 5%
Sarkosyl detergent prior to binding analysis by Western blotting.
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